Argenx Se ARGX
NASDAQ ARGX
$962.22 +16.40 (+1.73%)
At close: Sep 24, 2026 · 4:00 PM EDT

Argenx Se (ARGX) Shares Outstanding (2015 - 2026)

Argenx Se's (ARGX) quarterly Shares Outstanding (Entity) came in at $61.9 million in Q4 2025, up 1.85% on a YoY basis from $60.8 million in Q4 2024, and up 1.85% quarter-over-quarter from $60.8 million in Q4 2024.

Analysis

Argenx Se (ARGX) Shares Outstanding (2015 - 2026) Analysis & Trends

Argenx Se (ARGX) has reported Shares Outstanding (Entity) for 11 consecutive years, with $61.9 million the latest figure, recorded in Q4 2025.

  • For the quarter ending Q4 2025, Shares Outstanding (Entity) rose 1.85% year-over-year to $61.9 million; the trailing twelve-month figure through Dec 2025 stood at $61.9 million (up 1.85% YoY), and the FY2025 full-year result was $61.9 million, up 1.85% from the prior year.
  • Shares Outstanding (Entity) advanced to $61.9 million in Q4 2025 per ARGX's latest filing, from $60.8 million in the prior quarter.
  • Across five years, Shares Outstanding (Entity) topped out at $61.9 million in Q4 2025 and bottomed at $51.7 million in Q4 2021.
  • Historically, Shares Outstanding (Entity) has averaged $57.8 million across 5 years, with a median of $59.2 million in 2023.
  • The sharpest annual moves came in 2021 and 2025: Shares Outstanding (Entity) climbed 8.61% in 2021, then climbed 1.85% in 2025.
  • Over 5 years, Shares Outstanding (Entity) stood at $51.7 million in 2021, then rose by 7.21% to $55.4 million in 2022, then increased by 6.86% to $59.2 million in 2023, then gained by 2.65% to $60.8 million in 2024, then advanced by 1.85% to $61.9 million in 2025.
  • According to Business Quant data, Shares Outstanding (Entity) over the past three periods registered $61.9 million, $60.8 million, and $59.2 million for Q4 2025, Q4 2024, and Q4 2023 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shares Outstanding (Qtr)
1 Johnson & Johnson 649.01 Bn 628.25 Bn 17.26 Bn 2.41 Bn
2 AbbVie 468.55 Bn 462.03 Bn 12.70 Bn 1.77 Bn
3 Merck 365.49 Bn 358.40 Bn 12.21 Bn 2.47 Bn
4 Novartis Ag 272.39 Bn 265.10 Bn 11.24 Bn 1.94 Bn
5 Astrazeneca 253.18 Bn 247.96 Bn 12.86 Bn 1.55 Bn
6 Amgen 219.53 Bn 205.54 Bn 7.24 Bn 540.00 Mn
7 Gilead Sciences 187.85 Bn 184.59 Bn 6.22 Bn 1.24 Bn
8 Pfizer 160.56 Bn 149.16 Bn 10.94 Bn 5.70 Bn
9 Vertex Pharmaceuticals 130.81 Bn 122.96 Bn 2.84 Bn 253.70 Mn
10 Argenx Se 58.53 Bn 53.35 Bn 1.37 Bn 61.30 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 61.30 Mn
Mar 31, 2026 61.30 Mn
Dec 31, 2025 61.30 Mn
Sep 30, 2025 59.86 Mn
Jun 30, 2025 59.86 Mn
Mar 31, 2025 59.86 Mn
Dec 31, 2024 59.86 Mn
Sep 30, 2024 57.17 Mn
Jun 30, 2024 57.17 Mn
Mar 31, 2024 57.17 Mn
Dec 31, 2023 57.17 Mn
Sep 30, 2023 54.38 Mn
Jun 30, 2023 54.38 Mn
Mar 31, 2023 54.38 Mn
Dec 31, 2022 54.38 Mn
Sep 30, 2022 51.08 Mn
Jun 30, 2022 51.08 Mn
Mar 31, 2022 51.08 Mn
Dec 31, 2021 51.08 Mn
Sep 30, 2021 45.41 Mn
API Access

Argenx Se Shares Outstanding API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=shares-outstanding&ticker=ARGX&period=max&api_key=YOUR_API_KEY